Multidisciplinary Association For Psychedelic Studies

Organization Overview

Multidisciplinary Association For Psychedelic Studies is located in San Jose, CA. The organization was established in 1986. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2021, Multidisciplinary Association For Psychedelic Studies employed 42 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Multidisciplinary Association For Psychedelic Studies is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Multidisciplinary Association For Psychedelic Studies generated $23.6m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 23.2% each year . All expenses for the organization totaled $10.3m during the year ending 12/2021. While expenses have increased by 22.7% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.

Since 2020, Multidisciplinary Association For Psychedelic Studies has awarded 29 individual grants totaling $3,456,312. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

MEDICAL RESEARCH AND EDUCATION

Describe the Organization's Program Activity:

Part 3 - Line 4a

IN 2021, MAPS PRIMARILY FOCUSED ON SPONSOR ACTIVITIES RELATED TO ITS TWO MULTI-SITE PHASE 3 CLINICAL TRIALS OF MDMA-ASSISTED THERAPY FOR PTSD HOSTED AT SITES IN THE U.S., CANADA, AND ISRAEL. PEER-REVIEWED RESULTS OF THE FIRST PHASE 3 TRIAL WERE PUBLISHED IN NATURE MEDICINE IN MAY 2021 AND LATER NAMED AMONG THE TOP TEN BREAKTHROUGHS OF THE YEAR BY THE JOURNAL SCIENCE. THE SECOND PHASE 3 TRIAL BEGAN ENROLLMENT AT 13 SITES IN THE U.S. AND ISRAEL IN NOVEMBER 2020; THE FINAL DATA POINT IS EXPECTED TO BE COLLECTED IN NOVEMBER 2022. VOLUNTEERS WERE PEOPLE DIAGNOSED WITH MODERATE TO SEVERE, CHRONIC PTSD WHO WERE AT LEAST 18 YEARS OLD AND IN GOOD PHYSICAL HEALTH. THE TWO PHASE 3 TRIALS OF MDMA-ASSISTED THERAPY FOR PTSD ARE CONDUCTED UNDER U.S. FOOD AND DRUG ADMINISTRATION (FDA) GUIDELINES. IN 2020, MAPS BEGAN RECRUITMENT FOR A PHASE 2 TRIAL OF MDMA-ASSISTED THERAPY FOR PTSD IN EUROPE, AND THE FIRST PARTICIPANT WAS TREATED IN 2021. IN LATE 2017, MAPS BEGAN PRELIMINARY, PROMISING DISCUSSIONS WITH FDA AND DEA ABOUT THE ESTABLISHMENT OF A SPECIAL EXPANDED ACCESS PROGRAM, ALSO KNOWN AS COMPASSIONATE USE. THE PROGRAM IS DESIGNED TO ADDRESS URGENT AND LIFE-THREATENING CONDITIONS, IN PATIENTS WHO HAVE CURRENTLY FAILED TO OBTAIN RELIEF WITH EXITING TREATMENT OPTIONS, TO USE AN INVESTIGATIONAL TREATMENT ON A COMPASSIONATE BASIS AT THEIR OWN RISK AND AT THEIR OWN COST WHILE THE PHASE 3 STUDIES FOR THAT TREATMENT ARE STILL ONGOING. IN 2020, THE FDA APPROVED MAPS' EXPANDED ACCESS PROTOCOL FOR 50 SUBJECTS WITH TREATMENT-RESISTANT PTSD AND IN 2021, PATIENT SCREENING FOR THE PROGRAM BEGAN.EIGHT HUNDRED THERAPISTS COMPLETED THE 100-HOUR MDMA THERAPY TRAINING PROGRAM IN 2021, AND ADDITIONAL THERAPISTS IN OUR TRAINING PROGRAM COMPLETED THEIR CONSULTATION AND CLINICAL EXPERIENCE CRITERIA BY TREATING ONE PTSD PATIENT IN AN OPEN-LABEL PROTOCOL PROVIDING THE SAME TREATMENT DESIGN AS IN OUR PHASE 3 STUDY. MAPS' THERAPIST TRAINING TEAMS VIEWED VIDEOTAPES OF THE THERAPY SESSIONS AND PROVIDED SUPERVISION AND FEEDBACK TO THE THERAPISTS ON HOW WELL THEY WERE ADHERING TO OR TREATMENT MANUAL FOR MDMA-ASSISTED PSYCHOTHERAPY FOR PTSD. MAPS ENROLLED ADDITIONAL THERAPISTS IN OUR THERAPIST TRAINING PROTOCOL, MT1. IN THIS PROTOCOL, THERAPISTS IN OUR TRAINING PROGRAM CAN VOLUNTEER TO FULFILL THEIR EXPERIENTIAL ELECTIVE BY RECEIVING MDMA IN A THERAPEUTIC SETTING ADMINISTERED BY TWO CO-THERAPISTS FROM OUR THERAPIST TRAINING TEAM.MAPS CONDUCTED PUBLIC EDUCATION THROUGH PRESENTATIONS AT DOZENS OF PUBLIC CONFERENCES AND WEBINARS, PUBLISHING OUR FREE TRI-ANNUAL BULLETIN IN PRINT AND ONLINE, PUBLISHING EDUCATIONAL ARTICLES ON EIGHT WEBSITES AND SOCIAL MEDIA CHANNELS, AND BOOKS IN THE TRADE. IN 2021, MAPS EDUCATED MILLIONS THROUGH PROVIDING INTERVIEWS FOR HUNDREDS OF UNIQUE MEDIA EXPOSURES FROM ONLINE, BROADCAST, AND PRINT PUBLICATIONS INCLUDING NPR, CNN, NBC, CBS, ABC, TIME, NEWSWEEK, FORBES, ROLLING STONE, THE NEW YORK TIMES, THE WASHINGTON POST, FOX NEWS, STARS AND STRIPES, MILITARY TIMES, REUTERS, AND MANY MORE.THE ZENDO PROJECT'S PSYCHEDELIC HARM REDUCTION PROGRAM'S IN-PERSON SERVICES WERE CURTAILED DUE TO COVID-19. ZENDO PROJECT STAFF LEAD EFFORTS TO DEVELOP PILOT COMMUNITY- AND INSTITUTION-BASED HARM REDUCTION EDUCATION, PARTICULARLY FOR FIRST RESPONDERS, AND ONLINE PUBLIC EDUCATION PROGRAMS. ZENDO PROJECT EXPERTS DELIVERED TRAINING PROGRAMS FOR PEER-TO-PEER HARM REDUCTION PROVIDERS AND PRESENTED AT CONFERENCES.MAPS SERVED AS FISCAL SPONSOR TO ABOUT THREE DOZEN ENTITIES, PROVIDING ADMINISTRATIVE STRUCTURE AND A MECHANISM TO RECEIVE CHARITABLE DONATIONS. EACH ENTITY -- WHICH MAY BE EITHER A LIMITED-TERM PROJECT OR A NON-PROFIT STARTUP SEEKING (OR LIKELY TO SEEK) INDEPENDENT 501(C)(3) STATUS -- HAS A MISSION RELATED TO MAPS'.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Squire Patton Boggs
Legal
$409,206
Trans World Health Services
Consulting
$250,000
Cfo Selections Llc
Cfo/controller Services
$392,360
Maps Israel Ltd
Consulting
$160,493
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $7,396,449
All other contributions, gifts, grants, and similar amounts not included above$15,647,686
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$23,044,135
Total Program Service Revenue$208,885
Investment income $1,444
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $394,104
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory -$68,143
Miscellaneous Revenue$0
Total Revenue $23,580,425

Grants Awarded

Over the last fiscal year, Multidisciplinary Association For Psychedelic Studies has awarded $2,462,040 in support to 15 organizations.

Grant RecipientAmount

INDIGENOUS MEDICINE CONSERVATION FUND

Org PageRecipient Profile

Santa Cruz, CA

PURPOSE: GENERAL SUPPORT

$800,000

MAPS PUBLIC BENEFIT CORPORATION

PURPOSE: SCIENTIFIC RESEARCH FOR PUBLIC BENEFIT

$623,904

CENTER FOR CONSCIOUSNESS MEDICINE

Org PageRecipient Profile

Nevada City, CA

PURPOSE: GENERAL SUPPORT

$550,000

ENTHEA

PURPOSE: GENERAL SUPPORT

$136,000

CIT CLINICS

PURPOSE: GENERAL SUPPORT

$75,000

BROOKLYN PSYCHEDELIC SOCIETY INC

PURPOSE: GENERAL SUPPORT

$55,191
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 1 grants that Multidisciplinary Association For Psychedelic Studies has recieved totaling $100,000.

Awarding OrganizationAmount
Turnbull Family Foundation Inc

Greenwich, CT

PURPOSE: GENERAL SUPPORT

$100,000
View Grant Recipient Profile

Create an account to unlock the data you need.

or